Initiates Coverage on InVivo Therapeutics (NASDAQ:NVIV) began coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research note issued to investors on Monday morning. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Stock Down 5.1 % Shares of NASDAQ:NVIV opened at $0.92 on Monday. The company has a market capitalization of $2.86 […]

Leave a Reply

Your email address will not be published.

Previous post SemiLEDs (NASDAQ:LEDS) Earns Sell Rating from Analysts at
Next post Begins Coverage on Natural Alternatives International (NASDAQ:NAII)